PREPARATION AND PHARMACOLOGICAL EVALUATION OF ENANTIOMERS OF CERTAIN NONOXYGENATED APORPHINES - (+)- AND (-)-APORPHINE AND (+)- AND (-)-10-METHYLAPORPHINE

被引:14
作者
CANNON, JG [1 ]
RAGHUPATHI, R [1 ]
MOE, ST [1 ]
JOHNSON, AK [1 ]
LONG, JP [1 ]
机构
[1] UNIV IOWA,COLL MED,DEPT PHARMACOL,IOWA CITY,IA 52242
关键词
D O I
10.1021/jm00062a002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The subject compounds were prepared as a part of a continuing structure-activity study of the contrasting actions (agonism-antagonism) of (+)- and (-)-11-hydroxy-10-methylaporphine at serotonin (5-HT1A) receptors. None of the targeted nonoxygenated aporphine derivatives demonstrated significant activity in assays for any effects at serotonin 5-HT1A receptors. It is concluded that, in the aporphine series, serotonergic agonist or antagonism requires an alkyl group ortho to a phenolic OH group in the A ring.
引用
收藏
页码:1316 / 1318
页数:3
相关论文
共 11 条
[1]   ENANTIOMERS OF 11-HYDROXY-10-METHYLAPORPHINE HAVING OPPOSING PHARMACOLOGICAL EFFECTS AT 5-HT1A RECEPTORS [J].
CANNON, JG ;
MOE, ST ;
LONG, JP .
CHIRALITY, 1991, 3 (01) :19-23
[2]   (R)-(-)-10-METHYL-11-HYDROXYAPORPHINE - A HIGHLY SELECTIVE SEROTONERGIC AGONIST [J].
CANNON, JG ;
MOHAN, P ;
BOJARSKI, J ;
LONG, JP ;
BHATNAGAR, RK ;
LEONARD, PA ;
FLYNN, JR ;
CHATTERJEE, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (02) :313-318
[3]  
Finney D. J, 1962, PROBIT ANAL
[4]  
GALLIGAN JJ, 1992, J PHARMACOL EXP THER, V260, P306
[5]   SYNTHESIS AND DOPAMINE AGONIST AND ANTAGONIST EFFECTS OF (R)-(-) AND (S)-(+)-11-HYDROXY-N-NORMAL-PROPYLNORAPORPHINE [J].
GAO, YG ;
ZONG, R ;
CAMPBELL, A ;
KULA, NS ;
BALDESSARINI, RJ ;
NEUMEYER, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (07) :1392-1396
[6]  
Gattermann L., 1890, DTSCH CHEM GES, V23, P1218
[7]  
GOLDMAN ME, 1984, MOL PHARMACOL, V25, P18
[8]  
Long J., UNPUB
[9]   EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL-CYCLASE HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY [J].
MILLER, R ;
HORN, A ;
IVERSEN, L ;
PINDER, R .
NATURE, 1974, 250 (5463) :238-241
[10]  
Schoeler A., 1925, ARCH PHARM, V263, P81